Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Interventional × inebilizumab × Clear all

Phase

Status

Completed 5 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1

Interventions

pembrolizumab 493 Specimen Handling 389 Carboplatin 372 Magnetic Resonance Spectroscopy 356 Cisplatin 346 Cyclophosphamide 331 Radiotherapy 272 Gemcitabine 264 Bevacizumab 254 Paclitaxel 249 Biopsy 215 Drug Therapy 204 venetoclax 196 fludarabine 195 Capecitabine 190 Nivolumab 189 Oxaliplatin 187 Docetaxel 179 Injections 175 Fluorouracil 163 Dexamethasone 154 Radiosurgery 145 Pemetrexed 136 Rituximab 135 Standard of Care 124 durvalumab 121 atezolizumab 118 tislelizumab 116 Azacitidine 111 130-nm albumin-bound paclitaxel 110

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06987539 2026-03-16

THYME

Amgen

Phase 2 Recruiting

Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡